Viewing Study NCT02038920


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-02-20 @ 3:45 PM
Study NCT ID: NCT02038920
Status: COMPLETED
Last Update Posted: 2019-12-09
First Post: 2014-01-15
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase III Study of MLN0002 (300 mg) in Treatment of Crohn's Disease
Sponsor: Takeda
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Crohn's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Drug Therapy View